AChR α 5 Antibodies

Santa Cruz Biotechnology offers a broad range of AChR α 5 monoclonal antibodies for various research applications. AChR α 5 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AChR α 5 subunit is a critical component of the nicotinic acetylcholine receptor, playing a significant role in neurotransmission and synaptic plasticity. Research has shown that AChR α 5 influences cognitive functions and may have connections to various neurological disorders. Scientists studying AChR α 5 can gain valuable insights into potential therapeutic targets for conditions such as Alzheimer's disease and schizophrenia. Current research focuses on understanding how AChR α 5 functions in different neural pathways and its impact on brain development. Ongoing studies continue to reveal new aspects of AChR α 5's role in cellular signaling and synaptic transmission. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to neuroscience research and therapeutic development.